Follow the people · Insider

SM

Shankar Musunuri

Insider · Chief Executive Officer · OCGN

Shankar Musunuri files insider transactions with the SEC as a chief executive officer of Ocugen. We hold 1 disclosed purchase or sale filed since 13 December 2019, 1 of them in the last 90 days.

  • Files forOCGN
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure11 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 11 December 20199 September 2026Chief Executive Officer · Ocugen 66 Form 4 lines · source: SEC Form 4

Every transaction

66 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
66 of 66 shown
9 Sep 202611 Sep 2026SEC Form 42 dsold on the open marketOcugen468,727 sharesdown −4.2%up +0.0%
9 Sep 202611 Sep 2026SEC Form 42 dsold on the open marketOcugen57,264 sharesdown −4.2%up +0.0%
2 Jan 20266 Jan 2026SEC Form 44 dwas grantednot a tradeOcugen3,123,201 sharesdown −26.1%down −33.8%
2 Jan 20266 Jan 2026SEC Form 44 dwas grantednot a tradeOcugenderivative3,123,201 sharesdown −26.1%down −33.8%
2 Jan 20266 Jan 2026SEC Form 44 dwas grantednot a tradeOcugenderivative3,123,201 sharesdown −26.1%down −33.8%
2 Jan 20266 Jan 2026SEC Form 44 dwas grantednot a tradeOcugen3,123,201 sharesdown −26.1%down −33.8%
3 Jan 20256 Jan 2025SEC Form 43 dhad shares withheld for taxnot a tradeOcugen177,146 sharesup +14.0%up +13.3%
2 Jan 20256 Jan 2025SEC Form 44 dwas grantednot a tradeOcugenderivative1,827,485 sharesup +13.3%up +13.3%
3 Jan 20245 Jan 2024SEC Form 42 dhad shares withheld for taxnot a tradeOcugen180,204 sharesup +56.2%up +52.5%
2 Jan 20244 Jan 2024SEC Form 42 dwas grantednot a tradeOcugenderivative492,126 sharesup +55.0%up +56.2%
16 Feb 202317 Feb 2023SEC Form 41 dexercised options overnot a tradeOcugenderivative100,000 sharesdown −1.9%down −5.6%
16 Feb 202317 Feb 2023SEC Form 41 dexercised options overnot a tradeOcugen100,000 sharesdown −1.9%down −5.6%
16 Feb 202317 Feb 2023SEC Form 41 dsold on the open marketOcugen100,000 sharesdown −1.9%down −5.6%
17 Jan 202319 Jan 2023SEC Form 42 dexercised options overnot a tradeOcugenderivative100,000 sharesdown −19.0%down −12.1%
17 Jan 202319 Jan 2023SEC Form 42 dexercised options overnot a tradeOcugen100,000 sharesdown −19.0%down −12.1%
17 Jan 202319 Jan 2023SEC Form 42 dsold on the open marketOcugen100,000 sharesdown −19.0%down −12.1%
3 Jan 202317 Feb 2023SEC Form 445 dhad shares withheld for taxnot a tradeOcugen37,877 sharesdown −18.4%down −5.6%
3 Jan 20235 Jan 2023SEC Form 42 dwas grantednot a tradeOcugenderivative1,771,654 sharesdown −18.4%down −20.9%
3 Jan 20235 Jan 2023SEC Form 42 dwas grantednot a tradeOcugen1,475,410 sharesdown −18.4%down −20.9%
16 Dec 202220 Dec 2022SEC Form 44 dexercised options overnot a tradeOcugenderivative95,809 sharesdown −33.3%down −22.7%
16 Dec 202220 Dec 2022SEC Form 44 dexercised options overnot a tradeOcugen95,809 sharesdown −33.3%down −22.7%
16 Dec 202220 Dec 2022SEC Form 44 dsold on the open marketOcugen95,809 sharesdown −33.3%down −22.7%
14 Oct 202214 Oct 2022SEC Form 40 dexercised options overnot a tradeOcugenderivative100,000 sharesdown −34.6%down −34.6%
14 Oct 202214 Oct 2022SEC Form 40 dexercised options overnot a tradeOcugen100,000 sharesdown −34.6%down −34.6%
14 Oct 202214 Oct 2022SEC Form 40 dsold on the open marketOcugen100,000 sharesdown −34.6%down −34.6%
14 Jul 202215 Jul 2022SEC Form 41 dexercised options overnot a tradeOcugenderivative150,000 sharesdown −61.2%down −60.5%
14 Jul 202215 Jul 2022SEC Form 41 dexercised options overnot a tradeOcugen150,000 sharesdown −61.2%down −60.5%
14 Jul 202215 Jul 2022SEC Form 41 dsold on the open marketOcugen150,000 sharesdown −61.2%down −60.5%
13 May 202213 May 2022SEC Form 40 dexercised options overnot a tradeOcugenderivative125,000 sharesdown −51.4%down −51.4%
13 May 202213 May 2022SEC Form 40 dexercised options overnot a tradeOcugen125,000 sharesdown −51.4%down −51.4%
13 May 202213 May 2022SEC Form 40 dsold on the open marketOcugen125,000 sharesdown −51.4%down −51.4%
16 Mar 202218 Mar 2022SEC Form 42 dexercised options overnot a tradeOcugenderivative81,823 sharesdown −64.5%down −72.6%
16 Mar 202218 Mar 2022SEC Form 42 dexercised options overnot a tradeOcugen81,823 sharesdown −64.5%down −72.6%
16 Mar 202218 Mar 2022SEC Form 42 dsold on the open marketOcugen81,823 sharesdown −64.5%down −72.6%
14 Feb 202216 Feb 2022SEC Form 42 dexercised options overnot a tradeOcugenderivative90,000 sharesdown −72.0%down −73.3%
14 Feb 202216 Feb 2022SEC Form 42 dexercised options overnot a tradeOcugen90,000 sharesdown −72.0%down −73.3%
14 Feb 202216 Feb 2022SEC Form 42 dsold on the open marketOcugen90,000 sharesdown −72.0%down −73.3%
3 Jan 20225 Jan 2022SEC Form 42 dwas grantednot a tradeOcugenderivative1,253,299 sharesdown −78.4%down −75.6%
3 Jan 20225 Jan 2022SEC Form 42 dwas grantednot a tradeOcugen346,540 sharesdown −78.4%down −75.6%
16 Dec 202117 Dec 2021SEC Form 41 dwas grantednot a tradeOcugenderivative197,000 sharesdown −79.7%down −80.5%
16 Dec 202117 Dec 2021SEC Form 41 dsold on the open marketOcugen115,000 sharesdown −79.7%down −80.5%
16 Nov 202118 Nov 2021SEC Form 42 dwas grantednot a tradeOcugenderivative197,000 sharesdown −87.5%down −86.0%
16 Nov 202118 Nov 2021SEC Form 42 dsold on the open marketOcugen115,000 sharesdown −87.5%down −86.0%
1 Nov 20213 Nov 2021SEC Form 42 dexercised options overnot a tradeOcugenderivative115,367 sharesdown −92.7%down −92.0%
1 Nov 20213 Nov 2021SEC Form 42 dexercised options overnot a tradeOcugen115,367 sharesdown −92.7%down −92.0%
1 Nov 20213 Nov 2021SEC Form 42 dsold on the open marketOcugen115,367 sharesdown −92.7%down −92.0%
15 Oct 202115 Oct 2021SEC Form 40 dexercised options overnot a tradeOcugenderivative125,000 sharesdown −88.2%down −88.2%
15 Oct 202115 Oct 2021SEC Form 40 dexercised options overnot a tradeOcugen125,000 sharesdown −88.2%down −88.2%
15 Oct 202115 Oct 2021SEC Form 40 dsold on the open marketOcugen125,000 sharesdown −88.2%down −88.2%
15 Sep 202117 Sep 2021SEC Form 42 dexercised options overnot a tradeOcugenderivative125,000 sharesdown −86.5%down −87.1%
15 Sep 202117 Sep 2021SEC Form 42 dexercised options overnot a tradeOcugen125,000 sharesdown −86.5%down −87.1%
15 Sep 202117 Sep 2021SEC Form 42 dsold on the open marketOcugen125,000 sharesdown −86.5%down −87.1%
8 Jun 20219 Jun 2021SEC Form 41 dexercised options overnot a tradeOcugen22,800 sharesdown −89.9%down −89.0%
8 Jun 20219 Jun 2021SEC Form 41 dsold on the open marketOcugen22,800 sharesdown −89.9%down −89.0%
8 Jun 20219 Jun 2021SEC Form 41 dexercised options overnot a tradeOcugenderivative22,800 sharesdown −89.9%down −89.0%
7 Jun 20219 Jun 2021SEC Form 42 dexercised options overnot a tradeOcugen7,758 sharesdown −90.1%down −89.0%
7 Jun 20219 Jun 2021SEC Form 42 dsold on the open marketOcugen7,758 sharesdown −90.1%down −89.0%
7 Jun 20219 Jun 2021SEC Form 42 dexercised options overnot a tradeOcugenderivative7,758 sharesdown −90.1%down −89.0%
3 May 20213 May 2021SEC Form 40 dexercised options overnot a tradeOcugen195,809 sharesdown −93.5%down −93.5%
3 May 20213 May 2021SEC Form 40 dsold on the open marketOcugen195,809 sharesdown −93.5%down −93.5%
3 May 20213 May 2021SEC Form 40 dexercised options overnot a tradeOcugenderivative195,809 sharesdown −93.5%down −93.5%
1 Jan 20214 Jan 2021SEC Form 43 dwas grantednot a tradeOcugenderivative1,757,000 sharesdown −44.3%down −66.8%
7 May 20207 May 2020SEC Form 40 dwas grantednot a tradeOcugenderivative1,357,145 sharesup +209.1%up +209.1%
2 Jan 20203 Jan 2020SEC Form 41 dwas grantednot a tradeOcugenderivative933,528 sharesup +99.6%up +89.2%
12 Dec 201913 Dec 2019SEC Form 41 dbought on the open marketOcugen143,000 sharesup +191.4%up +200.0%
11 Dec 201913 Dec 2019SEC Form 42 dbought on the open marketOcugen263,000 sharesup +172.0%up +200.0%

Both percentages are the stock’s move, not Shankar Musunuri’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 66 of the 66 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.